[1,5-a]
[4,3-e]
[3,4-e]
[2,1-a]
[5,6-]
[1,5-c]
[1,2-a]
[4,5-e]
[4,5-f]
[5,4-f]
[4,5-d]
[3,2-b]
[3,2-c]
[2,3-c]
[6,1-b]
[2,3-f]
[3,4-f]
[6,1-]
[5,4-b]
[3,2-g]
[2,3-e]
[1,2-x]
[4,3-b]
[4,3-c]
[2,3-a]
[5,1-a]
[2,1-b]
[4,5-b]
[4,3-d]
[3,2-e]
[3,2-d]
[4,3-]
[4,3-a]
[1,5-d]
[4,5-c]
[3,4-a]
[3,4-d]
[3,4-c]
[2,3-d]
[4,5-g]
[2,1-e]
[2,3-g]
[5,1-c]
[6,5-]
[5,1-b]
[2,3-ij][2,4-b]
[3,4-]
[4,5-a]
[1,2-b]
[5,1-]
[1,2-f]
[3,4-g]
[2,1-]
[3,2-a]
[2,1-c]
[5,6-c]
[5,1-f]
[5,4-]
[5,4-e]
[4,5-]
[1,5-b]
[3,4-b]
[2,1-d]
[2,1-f]
[2,3-b]
[2,3-h]
[1,2-d]
[1,6-ad][1,7-a]
[3,2-h]
[3,2-f]
[5,6-b]
[6,5-b]
[5,4-d]
[4,5-h]
[4,3-g]
[1,2-c]
[5,4-c]
Order 22502-03-0 2-Methoxyethyl Acetoacetate
Order 394-41-2 3-Fluoro-4-nitrophenol
Order 206752-32-1 Azomethin-H-Monosodium Salt Hydrate
Order 1192027-04-5 N,N-Dimethyl-N'-(3-thioxo-3H-1,2,4-dithiazol-5-yl)formimidamide
Order 4439-20-7 N,N'-BIS(2-HYDROXYETHYL)ETHYLENEDIAMINE
Order 50907-23-8 5-(4-BROMOPHENYL)-1H-TETRAZOLE
Order 206008-32-4 2H-Indene-2,2-dicarboxylic acid,5-[2,2-bis(methoxycarbonyl)-4-pentynyl]-1,3-dihydro-, dimethyl ester
Order 180530-10-3 Methanesulfonamide, N-(3-iodophenyl)-
Order 648862-39-9 1H-Pyrazole-3-propanoic acid,5-(4-methylphenyl)-a-phenyl-1-[4-(trifluoromethyl)phenyl]-
Order 648862-67-3 1H-Pyrazole-3-propanoic acid,5-(1,3-benzodioxol-5-yl)-1-(2-chlorophenyl)-a-(3-methylphenyl)-
Order 648863-65-4 1H-Pyrazole-3-propanoic acid,a-(3-methylphenyl)-1-(4-methylphenyl)-5-[4-(2-oxo-1-pyrrolidinyl)phenyl]-
Order 63105-95-3 6-Thiadecaborate(1-), dodecahydro-, potassium
Order 648862-92-4 1H-Pyrazole-3-propanamide,1-(4-methoxyphenyl)-N-methyl-a-(3-methylphenyl)-5-(4-methylphenyl)-
Order 20600-96-8 3,3-Oxybis(1,2-propanediol)tetranitrate
Order 648863-37-0 1H-Pyrazole-5-propanoic acid,3-[3-(dimethylamino)phenyl]-a-(3-methylphenyl)-1-(4-methylphenyl)-
Order 648863-20-1 1H-Pyrazole-3-propanoic acid,5-(2-chloro-3-pyridinyl)-1-(2,4-dichlorophenyl)-a-(3-methylphenyl)-
Order 648862-77-5 1H-Pyrazole-3-propanoic acid,5-(3-methoxy-4-methylphenyl)-a-(3-methylphenyl)-1-(4-methylphenyl)-
Order 206010-80-2 HYPERCALCEMIA OF MALIGNANCY FACTOR (1-37) (HUMAN, RAT)
Order 648863-71-2 1H-Pyrazole-3-propanoic acid,5-(4-aminophenyl)-a-(3-methylphenyl)-1-(4-methylphenyl)-
Order 6310-63-0 2-[bis(4-dimethylaminophenyl)methyl]-4-chloro-phenol
Order 648863-16-5 1H-Pyrazole-5-propanoic acid,a-(3-methylphenyl)-3-(1-naphthalenyl)-1-(2-pyridinyl)-
Order 20600-81-1 1-(4-Chlorophenyl)-9,10-anthraquinone
Order 648863-14-3 1H-Pyrazole-3-propanoic acid,5-[4-(dimethylamino)phenyl]-a-(3-methylphenyl)-1-(2-pyridinyl)-
Order 6488-63-7 (1R,2R)-2-[(1aS,8aS)-4β-(3-Furyl)-octahydro-4aβ-methyl-8-methylene-2-oxooxireno[d][2]benzopyran-7α-yl]-2,6,6-trimethyl-5-oxo-3-cyclohexene-1-acetic acid methyl ester
Order 20601-21-2 2-Chloro-1-methylnaphthalene
Order 20601-76-7 At
Order 106-24-1 Geraniol
Order 1416134-49-0 (2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxamide
Order 3483-12-3 DL-1,4-Dithiothreitol
Order 78-70-6 Linalol
Order 625120-81-2 3-(N-Methylpentylamino)propionic acid hydrochloride
Order 877997-98-3 2-hydroxy-4,5-dimethoxybenzoic acid phenyl ester
Order 106981-52-6 2-(4-AMino-2-ethoxyphenyl)pthaliMide
Order 62452-73-7 1-Eth-1-ynyl-4-propylbenzene
20600-81-1,206008-32-4,20600-96-8,206010-80-2,20601-21-2,20601-76-7 Supplier | GOOCHEMICAL.COM
CMO CDMO service. GOOCHEMICAL.COM supply 20600-81-1,206008-32-4,20600-96-8,206010-80-2,20601-21-2,20601-76-7 and related compounds.
20600-96-8 206008-32-4 20601-76-7 20601-21-2 20600-81-1 206010-80-2